{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T20:12:03Z","timestamp":1778703123557,"version":"3.51.4"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":49,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Nantong Bureau of Science and Technology","award":["MS22022016"],"award-info":[{"award-number":["MS22022016"]}]},{"name":"Health Commission of Nantong","award":["MA2021002"],"award-info":[{"award-number":["MA2021002"]}]},{"name":"the Priority Academic Program Development of Nantong Talent Center","award":["2022-\u2162-609"],"award-info":[{"award-number":["2022-\u2162-609"]}]},{"name":"grants from Jiangsu Provincial Research Hospital","award":["YJXYY202204"],"award-info":[{"award-number":["YJXYY202204"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-45579-x","type":"journal-article","created":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T16:48:10Z","timestamp":1774457290000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["c-MYC enhances transcription of the type 1 diabetes mellitus associated gene BATF3 via promoter binding"],"prefix":"10.1038","volume":"16","author":[{"given":"Ying","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhicheng","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sihui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qijie","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weixia","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,25]]},"reference":[{"issue":"2","key":"45579_CR1","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1503\/cmaj.060244","volume":"175","author":"KM Gillespie","year":"2006","unstructured":"Gillespie, K. M. Type 1 diabetes: pathogenesis and prevention. CMAJ 175 (2), 165\u2013170 (2006).","journal-title":"CMAJ"},{"issue":"10117","key":"45579_CR2","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S0140-6736(18)30024-2","volume":"391","author":"R Barnett","year":"2018","unstructured":"Barnett, R. Type 1 diabetes. Lancet 391 (10117), 195 (2018).","journal-title":"Lancet"},{"issue":"7","key":"45579_CR3","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/nrendo.2017.39","volume":"13","author":"C Mathieu","year":"2017","unstructured":"Mathieu, C., Gillard, P. & Benhalima, K. Insulin analogues in type 1 diabetes mellitus: getting better all the time. Nat. Rev. Endocrinol. 13 (7), 385\u2013399 (2017).","journal-title":"Nat. Rev. Endocrinol."},{"issue":"7","key":"45579_CR4","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1038\/s41591-021-01418-2","volume":"27","author":"EK Sims","year":"2021","unstructured":"Sims, E. K. et al. 100 years of insulin: celebrating the past, present and future of diabetes therapy. Nat. Med. 27 (7), 1154\u20131164 (2021).","journal-title":"Nat. Med."},{"key":"45579_CR5","doi-asserted-by":"crossref","unstructured":"Powers, A. C. Type 1 diabetes mellitus: much progress, many opportunities. J. Clin. Invest., 131(8). (2021).","DOI":"10.1172\/JCI142242"},{"issue":"2","key":"45579_CR6","first-page":"123","volume":"38","author":"S Ejaz","year":"2013","unstructured":"Ejaz, S. & Wilson, T. Managing type 1 diabetes \u2013 a journey from starvation to insulin pump. Minerva Endocrinol. 38 (2), 123\u2013131 (2013).","journal-title":"Minerva Endocrinol."},{"issue":"5","key":"45579_CR7","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1007\/s00125-021-05398-3","volume":"64","author":"BJ von Scholten","year":"2021","unstructured":"von Scholten, B. J. et al. Current and future therapies for type 1 diabetes. Diabetologia 64 (5), 1037\u20131048 (2021).","journal-title":"Diabetologia"},{"key":"45579_CR8","doi-asserted-by":"crossref","unstructured":"Guilliams, M., Tamura, T. & Decrypting, D. C. development. Nat Immunol, 20(9): pp. 1090\u20131092. (2019).","DOI":"10.1038\/s41590-019-0457-3"},{"issue":"5","key":"45579_CR9","doi-asserted-by":"publisher","first-page":"102402","DOI":"10.1016\/j.isci.2021.102402","volume":"24","author":"SW Lukowski","year":"2021","unstructured":"Lukowski, S. W. et al. Absence of Batf3 reveals a new dimension of cell state heterogeneity within conventional dendritic cells. iScience 24 (5), 102402 (2021).","journal-title":"iScience"},{"key":"45579_CR10","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jaut.2016.03.007","volume":"71","author":"ST Ferris","year":"2016","unstructured":"Ferris, S. T., Carrero, J. A. & Unanue, E. R. Antigen presentation events during the initiation of autoimmune diabetes in the NOD mouse. J. Autoimmun. 71, 19\u201325 (2016).","journal-title":"J. Autoimmun."},{"issue":"11","key":"45579_CR11","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1038\/s41590-020-0786-2","volume":"21","author":"MA Ataide","year":"2020","unstructured":"Ataide, M. A. et al. BATF3 programs CD8(+) T cell memory. Nat. Immunol. 21 (11), 1397\u20131407 (2020).","journal-title":"Nat. Immunol."},{"issue":"4","key":"45579_CR12","doi-asserted-by":"publisher","first-page":"901","DOI":"10.4049\/jimmunol.2000228","volume":"205","author":"Z Qiu","year":"2020","unstructured":"Qiu, Z. et al. Batf3 Expression by CD8 T Cells Critically Regulates the Development of Memory Populations. J. Immunol. 205 (4), 901\u2013906 (2020).","journal-title":"J. Immunol."},{"issue":"7","key":"45579_CR13","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/nri3470","volume":"13","author":"TL Murphy","year":"2013","unstructured":"Murphy, T. L., Tussiwand, R. & Murphy, K. M. Specificity through cooperation: BATF-IRF interactions control immune-regulatory networks. Nat. Rev. Immunol. 13 (7), 499\u2013509 (2013).","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"45579_CR14","doi-asserted-by":"publisher","first-page":"8894","DOI":"10.1038\/s41467-024-53264-8","volume":"15","author":"T Zhong","year":"2024","unstructured":"Zhong, T. et al. TGF-beta-mediated crosstalk between TIGIT(+) Tregs and CD226(+)CD8(+) T cells in the progression and remission of type 1 diabetes. Nat. Commun. 15 (1), 8894 (2024).","journal-title":"Nat. Commun."},{"issue":"1","key":"45579_CR15","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/imr.12430","volume":"272","author":"ER Unanue","year":"2016","unstructured":"Unanue, E. R., Ferris, S. T. & Carrero, J. A. The role of islet antigen presenting cells and the presentation of insulin in the initiation of autoimmune diabetes in the NOD mouse. Immunol. Rev. 272 (1), 183\u2013201 (2016).","journal-title":"Immunol. Rev."},{"issue":"4","key":"45579_CR16","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.immuni.2014.09.012","volume":"41","author":"ST Ferris","year":"2014","unstructured":"Ferris, S. T. et al. A minor subset of Batf3-dependent antigen-presenting cells in islets of Langerhans is essential for the development of autoimmune diabetes. Immunity 41 (4), 657\u2013669 (2014).","journal-title":"Immunity"},{"issue":"27","key":"45579_CR17","doi-asserted-by":"publisher","first-page":"9571","DOI":"10.1073\/pnas.0503726102","volume":"102","author":"CA Klebanoff","year":"2005","unstructured":"Klebanoff, C. A. et al. Central memory self\/tumor-reactive CD8\u2009+\u2009T cells confer superior antitumor immunity compared with effector memory T cells. Proc. Natl. Acad. Sci. U S A. 102 (27), 9571\u20139576 (2005).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"45579_CR18","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.coi.2016.09.004","volume":"43","author":"JA Carrero","year":"2016","unstructured":"Carrero, J. A., Ferris, S. T. & Unanue, E. R. Macrophages and dendritic cells in islets of Langerhans in diabetic autoimmunity: a lesson on cell interactions in a mini-organ. Curr. Opin. Immunol. 43, 54\u201359 (2016).","journal-title":"Curr. Opin. Immunol."},{"issue":"7863","key":"45579_CR19","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/s41586-021-03552-w","volume":"594","author":"J Chiou","year":"2021","unstructured":"Chiou, J. et al. Interpreting type 1 diabetes risk with genetics and single-cell epigenomics. Nature 594 (7863), 398\u2013402 (2021).","journal-title":"Nature"},{"issue":"3","key":"45579_CR20","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1101\/gr.275992.121","volume":"32","author":"D Huang","year":"2022","unstructured":"Huang, D. & Ovcharenko, I. Enhancer-silencer transitions in the human genome. Genome Res. 32 (3), 437\u2013448 (2022).","journal-title":"Genome Res."},{"issue":"4","key":"45579_CR21","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.tibtech.2023.09.010","volume":"42","author":"B Bhatt","year":"2024","unstructured":"Bhatt, B., Garcia-Diaz, P. & Foight, G. W. Synthetic transcription factor engineering for cell and gene therapy. Trends Biotechnol. 42 (4), 449\u2013463 (2024).","journal-title":"Trends Biotechnol."},{"issue":"10","key":"45579_CR22","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1038\/s41401-021-00852-9","volume":"43","author":"JJ Zhuang","year":"2022","unstructured":"Zhuang, J. J. et al. Current strategies and progress for targeting the undruggable transcription factors. Acta Pharmacol. Sin. 43 (10), 2474\u20132481 (2022).","journal-title":"Acta Pharmacol. Sin"},{"issue":"3","key":"45579_CR23","first-page":"2756","volume":"16","author":"S Zhong","year":"2018","unstructured":"Zhong, S., Ge, J. & Yu, J. Y. Icariin prevents cytokine-induced beta-cell death by inhibiting NF-kappaB signaling. Exp. Ther. Med. 16 (3), 2756\u20132762 (2018).","journal-title":"Exp. Ther. Med."},{"issue":"6","key":"45579_CR24","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1080\/08820139.2022.2079419","volume":"51","author":"M Zandi","year":"2022","unstructured":"Zandi, M. et al. The Impact of STAT3 rs1053005 Variation on Type 1 Diabetes Mellitus Susceptibility: Association Study and in Silico Analysis. Immunol. Invest. 51 (6), 1908\u20131919 (2022).","journal-title":"Immunol. Invest."},{"key":"45579_CR25","doi-asserted-by":"publisher","first-page":"615371","DOI":"10.3389\/fimmu.2020.615371","volume":"11","author":"M Clark","year":"2020","unstructured":"Clark, M. et al. The Role of T Cell Receptor Signaling in the Development of Type 1 Diabetes. Front. Immunol. 11, 615371 (2020).","journal-title":"Front. Immunol."},{"key":"45579_CR26","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1146\/annurev.biochem.77.061307.091829","volume":"77","author":"P Tontonoz","year":"2008","unstructured":"Tontonoz, P. & Spiegelman, B. M. Fat and beyond: the diverse biology of PPARgamma. Annu. Rev. Biochem. 77, 289\u2013312 (2008).","journal-title":"Annu. Rev. Biochem."},{"issue":"6939","key":"45579_CR27","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/nature01667","volume":"423","author":"P Puigserver","year":"2003","unstructured":"Puigserver, P. et al. Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction. Nature 423 (6939), 550\u2013555 (2003).","journal-title":"Nature"},{"issue":"1","key":"45579_CR28","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28 (1), 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"45579_CR29","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 28 (11), 1947\u20131951 (2019).","journal-title":"Protein Sci."},{"issue":"D1","key":"45579_CR30","doi-asserted-by":"publisher","first-page":"D587","DOI":"10.1093\/nar\/gkac963","volume":"51","author":"M Kanehisa","year":"2023","unstructured":"Kanehisa, M. et al. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 51 (D1), D587\u2013D592 (2023).","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"45579_CR31","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk, D. et al. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 51 (D1), D638\u2013D646 (2023).","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"45579_CR32","doi-asserted-by":"publisher","first-page":"D39","DOI":"10.1093\/nar\/gkac907","volume":"51","author":"W Shen","year":"2023","unstructured":"Shen, W. et al. AnimalTFDB 4.0: a comprehensive animal transcription factor database updated with variation and expression annotations. Nucleic Acids Res. 51 (D1), D39\u2013D45 (2023).","journal-title":"Nucleic Acids Res."},{"key":"45579_CR33","doi-asserted-by":"publisher","first-page":"D174","DOI":"10.1093\/nar\/gkad1059","volume":"52(D1)","author":"I Rauluseviciute","year":"2024","unstructured":"Rauluseviciute, I. et al. JASPAR 2024: 20th anniversary of the open-access database of transcription factor binding profiles. Nucleic Acids Res. 52(D1), D174\u2013D182 (2024).","journal-title":"Nucleic Acids Res."},{"issue":"Suppl 1","key":"45579_CR34","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/s00508-023-02182-8","volume":"135","author":"M Lechleitner","year":"2023","unstructured":"Lechleitner, M. et al. [Diagnosis and insulin therapy of type 1 diabetes mellitus (Update 2023)]. Wien Klin. Wochenschr. 135 (Suppl 1), 98\u2013105 (2023).","journal-title":"Wien Klin. Wochenschr"},{"issue":"9911","key":"45579_CR35","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0140-6736(13)60591-7","volume":"383","author":"MA Atkinson","year":"2014","unstructured":"Atkinson, M. A., Eisenbarth, G. S. & Michels, A. W. Type 1 diabetes. Lancet 383 (9911), 69\u201382 (2014).","journal-title":"Lancet"},{"issue":"7","key":"45579_CR36","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1016\/j.immuni.2023.06.003","volume":"56","author":"AM Moreno","year":"2023","unstructured":"Moreno, A. M. et al. CXCR3 expression in regulatory T cells drives interactions with type I dendritic cells in tumors to restrict CD8(+) T cell antitumor immunity. Immunity 56 (7), 1613\u20131630e5 (2023).","journal-title":"Immunity"},{"key":"45579_CR37","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.mcp.2018.11.003","volume":"43","author":"S Han","year":"2019","unstructured":"Han, S. et al. Genes and transcription factors related to the adverse effects of maternal type I diabetes mellitus on fetal development. Mol. Cell. Probes. 43, 64\u201371 (2019).","journal-title":"Mol. Cell. Probes"},{"issue":"21","key":"45579_CR38","doi-asserted-by":"publisher","first-page":"3828","DOI":"10.1002\/1878-0261.13319","volume":"16","author":"G Donati","year":"2022","unstructured":"Donati, G. & Amati, B. MYC and therapy resistance in cancer: risks and opportunities. Mol. Oncol. 16 (21), 3828\u20133854 (2022).","journal-title":"Mol. Oncol."},{"issue":"11","key":"45579_CR39","doi-asserted-by":"publisher","first-page":"6456","DOI":"10.1093\/nar\/gkab484","volume":"49","author":"S Zhu","year":"2021","unstructured":"Zhu, S. et al. RNA pull-down confocal nanoscanning (RP-CONA) detects quercetin as pri-miR-7\/HuR interaction inhibitor that decreases alpha-synuclein levels. Nucleic Acids Res. 49 (11), 6456\u20136473 (2021).","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"45579_CR40","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12943-020-01291-6","volume":"20","author":"SK Madden","year":"2021","unstructured":"Madden, S. K. et al. Taking the Myc out of cancer: toward therapeutic strategies to directly inhibit c-Myc. Mol. Cancer. 20 (1), 3 (2021).","journal-title":"Mol. Cancer"},{"issue":"4","key":"45579_CR41","doi-asserted-by":"publisher","first-page":"831","DOI":"10.2337\/db20-1185","volume":"70","author":"PS Linsley","year":"2021","unstructured":"Linsley, P. S., Greenbaum, C. J. & Nepom, G. T. Uncovering Pathways to Personalized Therapies in Type 1 Diabetes. Diabetes 70 (4), 831\u2013841 (2021).","journal-title":"Diabetes"},{"issue":"1","key":"45579_CR42","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.cell.2012.03.003","volume":"149","author":"CV Dang","year":"2012","unstructured":"Dang, C. V. MYC on the path to cancer. Cell 149 (1), 22\u201335 (2012).","journal-title":"Cell"},{"issue":"9","key":"45579_CR43","doi-asserted-by":"publisher","first-page":"a014399","DOI":"10.1101\/cshperspect.a014399","volume":"4","author":"SR Hann","year":"2014","unstructured":"Hann, S. R. MYC cofactors: molecular switches controlling diverse biological outcomes. Cold Spring Harb Perspect. Med. 4 (9), a014399 (2014).","journal-title":"Cold Spring Harb Perspect. Med."},{"key":"45579_CR44","doi-asserted-by":"crossref","unstructured":"Marchingo, J. M. et al. Quantitative analysis of how Myc controls T cell proteomes and metabolic pathways during T cell activation. Elife, 9. (2020).","DOI":"10.7554\/eLife.53725"},{"key":"45579_CR45","doi-asserted-by":"crossref","unstructured":"Zhu, C. et al. Tim-3 adaptor protein Bat3 is a molecular checkpoint of T cell terminal differentiation and exhaustion. Sci. Adv., 7(18). (2021).","DOI":"10.1126\/sciadv.abd2710"},{"issue":"9","key":"45579_CR46","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1038\/ni.2943","volume":"15","author":"C Chou","year":"2014","unstructured":"Chou, C. et al. c-Myc-induced transcription factor AP4 is required for host protection mediated by CD8\u2009+\u2009T cells. Nat. Immunol. 15 (9), 884\u2013893 (2014).","journal-title":"Nat. Immunol."},{"issue":"1","key":"45579_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2249.2006.03244.x","volume":"148","author":"TP Di Lorenzo","year":"2007","unstructured":"Di Lorenzo, T. P., Peakman, M. & Roep, B. O. Translational mini-review series on type 1 diabetes: Systematic analysis of T cell epitopes in autoimmune diabetes. Clin. Exp. Immunol. 148 (1), 1\u201316 (2007).","journal-title":"Clin. Exp. Immunol."},{"issue":"7","key":"45579_CR48","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.2337\/db19-0119","volume":"68","author":"S Ahmed","year":"2019","unstructured":"Ahmed, S. et al. Standardizing T-Cell Biomarkers in Type 1 Diabetes: Challenges and Recent Advances. Diabetes 68 (7), 1366\u20131379 (2019).","journal-title":"Diabetes"},{"key":"45579_CR49","doi-asserted-by":"publisher","first-page":"371","DOI":"10.2147\/OTT.S366627","volume":"16","author":"A D\u2019Avola","year":"2023","unstructured":"D\u2019Avola, A. et al. Spotlight on New Therapeutic Opportunities for MYC-Driven Cancers. Onco Targets Ther. 16, 371\u2013383 (2023).","journal-title":"Onco Targets Ther."},{"issue":"6","key":"45579_CR50","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1158\/0008-5472.CAN-22-0302","volume":"82","author":"RM Chabanon","year":"2022","unstructured":"Chabanon, R. M. & Postel-Vinay, S. A Novel Synthetic Lethal Approach to Target MYC-Driven Cancers. Cancer Res. 82 (6), 969\u2013971 (2022).","journal-title":"Cancer Res."},{"issue":"10","key":"45579_CR51","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1038\/nrc904","volume":"2","author":"S Pelengaris","year":"2002","unstructured":"Pelengaris, S., Khan, M. & Evan, G. c-MYC: more than just a matter of life and death. Nat. Rev. Cancer. 2 (10), 764\u2013776 (2002).","journal-title":"Nat. Rev. Cancer"},{"issue":"5","key":"45579_CR52","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.ccell.2019.10.001","volume":"36","author":"H Han","year":"2019","unstructured":"Han, H. et al. Small-Molecule MYC Inhibitors Suppress Tumor Growth and Enhance Immunotherapy. Cancer Cell. 36 (5), 483\u2013497e15 (2019).","journal-title":"Cancer Cell."},{"issue":"9","key":"45579_CR53","doi-asserted-by":"publisher","first-page":"491","DOI":"10.31083\/ph.2018.8480","volume":"73","author":"X Shi","year":"2018","unstructured":"Shi, X. et al. JQ1: a novel potential therapeutic target. Pharmazie 73 (9), 491\u2013493 (2018).","journal-title":"Pharmazie"},{"key":"45579_CR54","doi-asserted-by":"crossref","unstructured":"Megiorni, F. et al. OTX015 Epi-Drug Exerts Antitumor Effects in Ovarian Cancer Cells by Blocking GNL3-Mediated Radioresistance Mechanisms: Cellular, Molecular and Computational Evidence. Cancers (Basel), 13(7). (2021).","DOI":"10.3390\/cancers13071519"},{"issue":"4","key":"45579_CR55","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1158\/1078-0432.CCR-19-1853","volume":"26","author":"J Cidado","year":"2020","unstructured":"Cidado, J. et al. AZD4573 Is a Highly Selective CDK9 Inhibitor That Suppresses MCL-1 and Induces Apoptosis in Hematologic Cancer Cells. Clin. Cancer Res. 26 (4), 922\u2013934 (2020).","journal-title":"Clin. Cancer Res."},{"key":"45579_CR56","doi-asserted-by":"crossref","unstructured":"Joshi, H. et al. The Pharmacological Implications of Flavopiridol: An Updated Overview. Molecules, 28(22). (2023).","DOI":"10.3390\/molecules28227530"},{"key":"45579_CR57","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.cytogfr.2017.03.004","volume":"35","author":"J Gnanaprakasam","year":"2017","unstructured":"Gnanaprakasam, J., Sherman, J. W. & Wang, R. MYC and HIF in shaping immune response and immune metabolism. Cytokine Growth Factor. Rev. 35, 63\u201370 (2017).","journal-title":"Cytokine Growth Factor. Rev."},{"issue":"6","key":"45579_CR58","doi-asserted-by":"publisher","first-page":"e0156006","DOI":"10.1371\/journal.pone.0156006","volume":"11","author":"MI Riquelme","year":"2016","unstructured":"Riquelme, M. I. & Lubovac-Pilav, Z. Gene Co-Expression Network Analysis for Identifying Modules and Functionally Enriched Pathways in Type 1 Diabetes. PLoS One. 11 (6), e0156006 (2016).","journal-title":"PLoS One"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45579-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45579-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45579-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T20:03:01Z","timestamp":1778702581000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45579-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,25]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["45579"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-45579-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,25]]},"assertion":[{"value":"11 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Ethics Committee of the Affiliated Hospital of Nantong University(Approval Number: 2021-K085-01) on August 10, 2021. And it was conducted in accordance with the principles of the Declaration of Helsinki. Written informed consent was obtained from all participants or their legal guardians prior to participation in the study. The confidentiality of patient data was ensured throughout the study, and all personal identifiers were removed to protect the privacy of the individuals involved.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}}],"article-number":"14976"}}